HISTORICAL FACTS: Evogene | History Defined

Evogene Q2 Revenue Grows 131% YoY, Here Is What You Need To Know

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) Q2 2022 revenue was $312,000, an increase of 131% compared to $135,000 in the same period the previous year.

Benzinga · Aug 31, 2022

Why Hill International Shares Are Trading Higher By 58%: Here Are 25 Stocks Moving Premarket

Gainers Hill International, Inc. (NYSE: HIL) shares rose 58.1% to $2.75 in pre-market trading after the company agreed to be acquired by Global Infrastructure Solutions Inc. for $2.85 per share.

Benzinga · Aug 17, 2022

Evogene Q1 Revenue Decreases 28.82% YoY, What About Debt?

Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) released its financial results for the first quarter ended March 31, 2022, revealing revenue of $237,000 in comparison to $333,000 in the same period the previous year.

Benzinga · May 26, 2022

Evogene Co, 'When Biology Meets Disruptive Technologies,' Confirms Earnings Results Release Date

Computational biology company Evogene Ltd. (NASDAQ: EVGN)  will release its financial results for the full year and fourth quarter of 2021 on March 10, 2022.

Benzinga · Feb 15, 2022

Certain Marijuana Varieties Have 'Impressive' Pain Relief Properties, Evogene's Cannonic's Pre-Clinical Study Confirms

Medical grade cannabis products developer Canonic Ltd., a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), revealed Tuesday that it had seen positive results in pre-clinical studies in inflammatory and pain model systems.

Benzinga · Jan 18, 2022